ANTI-FCRN ANTIBODIES

The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.

Saved in:
Bibliographic Details
Main Authors SHAW STEVAN GRAHAM, LAWSON ALASTAIR DAVID GRIFFITHS, FINNEY HELENE MARGARET, KEVORKIAN LARA, SARKAR KAUSHIK, SMITH BRYAN JOHN, ATHERFOLD PAUL ALAN, TYSON KERRY LOUISE, MEIER CHRISTOPH
Format Patent
LanguageEnglish
Korean
Published 15.01.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.
Bibliography:Application Number: KR20147032580